Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 50% increase over the number of companies inspected in the previous quarter, when two companies received two inspections.
Most of the companies inspected at the time were involved in the Drugs sector. The second most common type of company inspected worked in the Food and Cosmetics sector.
There was one company in line with FDA regulations that does not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
AKI, Inc. | Drugs | 07/20/2023 | Voluntary Action Indicated (VAI) |
Ardent Mills, LLC | Food and Cosmetics | 08/09/2023 | No Action Indicated (NAI) |
Surgery Pharmacy Services, Inc. | Drugs | 07/07/2023 | Official Action Indicated (OAI) |